HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hatim F Daginawala Selected Research

AG 85

6/2013Diagnosis of tuberculosis infection based on synthetic peptides from Mycobacterium tuberculosis antigen 85 complex.
8/2010Diagnostic markers for tuberculosis ascites: a preliminary study.
7/2007Diagnosis of tuberculosis in an Indian population by an indirect ELISA protocol based on detection of Antigen 85 complex: a prospective cohort study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hatim F Daginawala Research Topics

Disease

13Infections
12/2020 - 06/2005
7Meningeal Tuberculosis (Tuberculous Meningitis)
01/2016 - 06/2005
5Tuberculosis (Tuberculoses)
03/2016 - 07/2007
5Ischemic Stroke
04/2015 - 04/2009
3Stroke (Strokes)
10/2016 - 07/2012
3Latent Tuberculosis
07/2016 - 07/2015
2Brucellosis (Malta Fever)
01/2023 - 12/2020
2Herpes Simplex Encephalitis (Herpes Encephalitis)
01/2016 - 08/2011
2Meningitis
09/2006 - 11/2003
2Nervous System Diseases (Neurological Disorders)
09/2006 - 11/2003
1Central Nervous System Viral Diseases
11/2020
1Virus Diseases (Viral Diseases)
11/2020
1Hypertension (High Blood Pressure)
10/2016
1Thrombosis (Thrombus)
07/2016
1Bacterial Meningitis
02/2016
1Chronic Disease (Chronic Diseases)
04/2015
1Disease Progression
01/2015
1Extrapulmonary Tuberculosis
02/2014
1Infarction (Infarctions)
07/2012
1Ascites
08/2010
1Chikungunya Fever
02/2010
1Inflammation (Inflammations)
01/2010
1Pheochromocytoma
11/2009
1Ischemia
11/2009
1Intracranial Sinus Thrombosis (Sinus Thrombosis)
09/2006
1Glioblastoma (Glioblastoma Multiforme)
05/2006
1Neuroblastoma
05/2006
1Central Nervous System Tuberculosis
06/2005

Drug/Important Bio-Agent (IBA)

11AntigensIBA
12/2020 - 11/2003
9Biomarkers (Surrogate Marker)IBA
01/2023 - 07/2012
6Proteins (Proteins, Gene)FDA Link
01/2023 - 06/2005
4CytokinesIBA
07/2015 - 10/2009
3Tuberculin (PPD)IBA
07/2016 - 01/2014
3GoldIBA
07/2016 - 01/2014
3Heat-Shock Proteins (Heat-Shock Protein)IBA
03/2016 - 09/2006
3Peptides (Polypeptides)IBA
06/2015 - 09/2010
3AG 85IBA
06/2013 - 07/2007
2Trypsin InhibitorsIBA
10/2016 - 07/2012
2Fibrinolytic Agents (Antithrombotic Agents)IBA
07/2016 - 09/2006
2AntibodiesIBA
01/2016 - 04/2015
2Interleukin-10 (Interleukin 10)IBA
07/2012 - 10/2009
2ImmunosorbentsIBA
08/2010 - 02/2010
2EnzymesIBA
08/2010 - 02/2010
2Immunoglobulin G (IgG)IBA
08/2010 - 02/2010
2Immunoglobulin M (IgM)IBA
08/2010 - 02/2010
2Adenosine DeaminaseIBA
09/2007 - 03/2006
1DNA (Deoxyribonucleic Acid)IBA
11/2020
1DNA-Directed RNA Polymerases (RNA Polymerase)IBA
11/2020
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
11/2020
1Phosphopyruvate Hydratase (Enolase)IBA
10/2016
1Ribosomal DNA (rDNA)IBA
02/2016
1EpitopesIBA
01/2016
1BCG VaccineFDA Link
01/2016
1Glycoproteins (Glycoprotein)IBA
01/2016
1Interferon-gamma (Interferon, gamma)IBA
07/2015
1VaccinesIBA
04/2015
1AerosolsIBA
04/2015
1HaptoglobinsIBA
01/2015
1Transferrin (beta 2 Transferrin)IBA
01/2015
1ProteomeIBA
01/2015
1Staphylococcal Protein A (Protein A)IBA
08/2011
1ischemia-modified albuminIBA
01/2011
1Free RadicalsIBA
11/2009
1AntioxidantsIBA
11/2009
1Interleukin-2 (IL2)IBA
10/2009
1inter-alpha-inhibitorIBA
04/2009
1Conditioned Culture MediaIBA
05/2006

Therapy/Procedure

1Lasers (Laser)
01/2015